CoChat
Sign Up
Cited by 70Cancer, Stress, Anesthesia, and Immune ResponseImmune Cell Function and InteractionImmunotherapy and Immune Responses

The DOI matches its Crossref record; 36 of the 39 references it cites were found in a registry or an index.

Perioperative Influenza Vaccination Reduces Postoperative Metastatic Disease by Reversing Surgery-Induced Dysfunction in Natural Killer Cells

Tai, Lee-Hwa, Zhang, Jiqing, Scott, Karen J., de Souza, Christiano Tanese, Alkayyal, Almohanad A., Ananth, Anu Abhirami, Sahi, Shalini, Adair, Robert A., Mahmoud, Ahmad B., Sad, Subash, Bell, John C., Makrigiannis, Andrew P., Melcher, Alan A., Auer, Rebecca C.·2013·Clinical Cancer Research
DOI 10.1158/1078-0432.ccr-13-0246

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Purpose: Surgical removal of solid primary tumors is an essential component of cancer treatment. Surgery-induced dysfunction in natural killer (NK) cells has been linked to the development of metastases in animal models and patients with cancer. We investigated the activation of NK cells using influenza vaccine in the perioperative period to eradicate micrometastatic disease. Experimental Design: Both the B16lacZ and 4T1 tumor models in immunocompetent mice were used to assess the in vivo efficacy of perioperative influenza vaccine administration. In healthy human donors and cancer surgery patients, we assessed NK cell function pre- and post-influenza vaccination using both in vivo and ex vivo assays. Results: Using the TLR3 agonist poly(I:C), we showed as proof-of-principle that perioperative administration of a nonspecific innate immune stimulant can inhibit surgery-induced dysfunction in NK cells and attenuate metastases. Next, we assessed a panel of prophylactic vaccines for NK cell activation and determined that inactivated influenza vaccine was the best candidate for perioperative administration. Perioperative influenza vaccine significantly reduced tumor metastases and improved NK cytotoxicity in preclinical tumor models. Significantly, IFNα is the main cytokine mediator for the therapeutic effect of influenza vaccination. In human studies, influenza vaccine significantly enhanced NK cell activity in healthy human donors and cancer surgery patients. Conclusion: These results provide the preclinical rationale to pursue future clinical trials of perioperative NK cell activation, using vaccination in cancer surgery patients. Research into perioperative immune therapy is warranted to prevent immune dysfunction following surgery and eradicate metastatic disease. Clin Cancer Res; 19(18); 5104–15. ©2013 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-13-0246

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

Sorted by citations

See all 70

Related

See all

Metadata

Authors
Tai, L.-H., Zhang, J., Scott, K. J., de Souza, C. T., Alkayyal, A. A., Ananth, A. A., Sahi, S., Adair, R. A., Mahmoud, A. B., Sad, S., Bell, J. C., Makrigiannis, A. P., Melcher, A. A., & Auer, R. C.
Affiliations
University of Ottawa (CA)
Corresponding author
Auer, Rebecca C.
ORCID
Venue
Clinical Cancer Research
Publisher
American Association for Cancer Research (AACR)
Published
2013-09-15
Volume
19
Issue
18
Pages
5104-5115
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
DOI
10.1158/1078-0432.ccr-13-0246
OpenAlex
W2153129739
Cited by
70
References
39
Citations by year
2026: 1 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 2 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 7 · 2013: 2
FWCI
4.50
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
natural killer cells, NK cell dysfunction, cancer surgery, metastasis, micrometastatic disease, NK cell activation, interferon-alpha, poly(I:C), TLR3 agonist, prophylactic vaccines, B16F10 melanoma, 4T1 breast cancer, cancer immunotherapy
MeSH terms
Animals, Cytotoxicity, Immunologic, Humans, Influenza Vaccines, Killer Cells, Natural, Lung Neoplasms, Lymphocyte Activation, Melanoma, Experimental, Mice, Inbred BALB C, Mice, Inbred C57BL, Postoperative Period, Surgical Procedures, Operative, Tumor Cells, Cultured, Vaccination, Mice, Knockout, Perioperative Care, Mice, Receptor, Interferon alpha-beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review